NCT01945333

Brief Summary

The purpose of this study is to develop and pilot test personalized and scalable approaches to Cognitive Remediation (CR) for schizophrenia and schizoaffective disorder. The intent is to more clearly define the therapeutic targets important to the facilitation of cognitive and functional improvement so that clinicians know how to customize cognitive interventions and deliver treatment in a more effective, efficient and personally relevant manner.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
122

participants targeted

Target at P75+ for not_applicable schizophrenia

Timeline
Completed

Started Sep 2013

Longer than P75 for not_applicable schizophrenia

Geographic Reach
1 country

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2013

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

September 13, 2013

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 18, 2013

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 2, 2017

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 20, 2019

Completed
Last Updated

September 16, 2020

Status Verified

September 1, 2020

Enrollment Period

4.1 years

First QC Date

September 13, 2013

Last Update Submit

September 11, 2020

Conditions

Keywords

Cognitive remediationSchizophreniaSchizoaffective disorder

Outcome Measures

Primary Outcomes (1)

  • Feasibility

    Feasibility of conducting a larger trial will be measured by recruitment, feasibility of enrollment, stratification, blinding and assessment, acceptability of randomization, retention of subjects

    Two years

Secondary Outcomes (2)

  • Change in neurocognition from baseline to treatment end-point

    10 weeks

  • Change in neurocognition from baseline to 3-month follow-up

    5.5 to 6 months

Other Outcomes (8)

  • Tone Matching Ability - Treatment end-point

    10 weeks

  • UCSD Performance-Based Skills Assessment (UPSA)-Brief - treatment end-point

    10 weeks

  • Structured Clinical Interview for the Positive and Negative Syndrome Scale (SCI-PANSS) - Treatment end-point

    10 weeks

  • +5 more other outcomes

Study Arms (4)

Brain Basics for Impaired Tone Matchers

ACTIVE COMPARATOR

Cognitive remediation includes sensory processing training

Behavioral: Cognitive remediation

Brain Basics for Intact Tone Matchers

ACTIVE COMPARATOR

Cognitive remediation includes sensory processing training

Behavioral: Cognitive remediation

Brain Training for Impaired Tone Matcher

ACTIVE COMPARATOR

Cognitive remediation does not include sensory processing training

Behavioral: Cognitive remediation

Brain Training for Intact Tone Matchers

ACTIVE COMPARATOR

Cognitive remediation does not include sensory processing training

Behavioral: Cognitive remediation

Interventions

Cognitive remediation sessions include working on computer based cognitive exercises and participating in a verbal discussion.

Brain Basics for Impaired Tone MatchersBrain Basics for Intact Tone MatchersBrain Training for Impaired Tone MatcherBrain Training for Intact Tone Matchers

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnostic and Statistical Manual-IV (DSM-IV) diagnosis of schizophrenia or schizoaffective disorder
  • Age 18 to 65
  • English speaking
  • Psychiatrically stable, verified by current living/treatment status

You may not qualify if:

  • Indication of mental retardation, determined by estimated IQ of less than 70
  • Hearing or visual impairment that precludes completing assessments
  • Neurologic illness that may affect brain physiology (e.g. Parkinson's, seizure disorder, epilepsy)
  • Current substance dependence symptoms in the past 6 weeks
  • Participation in cognitive remediation in the 12 months prior to study entry.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Williamsburg Clinic

Brooklyn, New York, 11206, United States

Location

Institute for Community Living

Brooklyn, New York, 11207, United States

Location

Nyspi/ Cumc

New York, New York, 10032, United States

Location

The Bridge Inc

New York, New York, 10040, United States

Location

FEGS Bronx Mental Health Clinic

The Bronx, New York, 10467, United States

Location

Related Publications (1)

  • Medalia A, Saperstein AM, Qian M, Javitt DC. Impact of baseline early auditory processing on response to cognitive remediation for schizophrenia. Schizophr Res. 2019 Jun;208:397-405. doi: 10.1016/j.schres.2019.01.012. Epub 2019 Jan 18.

MeSH Terms

Conditions

SchizophreniaPsychotic Disorders

Interventions

Cognitive Remediation

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Alice Medalia, PhD

    NYSPI

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Psychiatrist

Study Record Dates

First Submitted

September 13, 2013

First Posted

September 18, 2013

Study Start

September 1, 2013

Primary Completion

October 2, 2017

Study Completion

March 20, 2019

Last Updated

September 16, 2020

Record last verified: 2020-09

Locations